Open Access · CC BY-NC 4.0
Maximal renin–angiotensin system blockade for optimal management of cardiovascular-kidney-metabolic syndrome
Clinical Hypertension · 2026 · 32
DOI: 10.5646/ch.2026.32.e48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hypertension, 2026. Verfasst von Hae-Young Lee. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lee, H. (2026). Maximal renin–angiotensin system blockade for optimal management of cardiovascular-kidney-metabolic syndrome. Clinical Hypertension, 32. https://doi.org/10.5646/ch.2026.32.e48
Vancouver
Lee H. Maximal renin–angiotensin system blockade for optimal management of cardiovascular-kidney-metabolic syndrome. Clinical Hypertension. 2026;32. doi:10.5646/ch.2026.32.e48
BibTeX
@article{Lee2026,
author = {Lee, Hae-Young},
title = {Maximal renin–angiotensin system blockade for optimal management of cardiovascular-kidney-metabolic syndrome},
journal = {Clinical Hypertension},
year = {2026},
volume = {32},
doi = {10.5646/ch.2026.32.e48}
}
EUVIMED